Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark
Viktoria Papp(Copenhagen University Hospital), Thor Petersen(Aarhus University Hospital), Michael Broksgaard Jensen(University of Southern Denmark), Magnus Christian Lydolph(University of Southern Denmark), Matthias Kant(Sygehus Sønderjylland), Nils Koch‐Henriksen(Aarhus University Hospital), Zsolt Illés(Universität Hamburg), Poul Erik Jensen(University of Copenhagen), J. Zs. Mezei(University of Southern Denmark), Tove Christensen(University of Southern Denmark), Shanu F. Roemer(Mayo Clinic), Egon Stenager(Copenhagen University Hospital), Helle Hvilsted Nielsen(University of Southern Denmark), Jette Lautrup Frederiksen(University of Copenhagen), Lene Rosendahl(University of Southern Denmark), Kristina B. Svendsen(University of Southern Denmark), Niels H. H. Heegaard(Statens Serum Institut), Claudia Pfleger(St. Claraspital), Finn Sellebjerg(Danish Multiple Sclerosis Center), Annett Evelyn Petersen(University of Southern Denmark), Melinda Magyari(University of Copenhagen)
Cited by 104
Related Papers
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines
|The Lancet Neurology|2016|863
Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis
|Brain|2007|714
2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
|The Lancet Neurology|2021|646
Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis
|The Lancet Neurology|2017|572